These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32132314)

  • 61. Digoxin and reduction in mortality in systolic and diastolic heart failure at low serum digoxin concentrations.
    Rahimtoola SH
    Eur Heart J; 2006 Jul; 27(13):1630; author reply 1630-1. PubMed ID: 16760215
    [No Abstract]   [Full Text] [Related]  

  • 62. Therapeutic drug monitoring of digoxin-20 years of experience.
    Grześk G; Stolarek W; Kasprzak M; Krzyżanowski M; Szadujkis-Szadurska K; Wiciński M; Grześk E
    Pharmacol Rep; 2018 Feb; 70(1):184-189. PubMed ID: 29414149
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Therapeutic monitoring of digoxin and antiepileptic drugs in Egypt and Saudi Arabia.
    EL Desoky ES; AL-Ghamdi HA; Halaby FH; Al-Beshri M
    Ther Drug Monit; 2003 Apr; 25(2):211-4. PubMed ID: 12657916
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of digoxin noncompliance on hospitalization and mortality in patients with heart failure in long-term therapy: a prospective cohort study.
    Miura T; Kojima R; Mizutani M; Shiga Y; Takatsu F; Suzuki Y
    Eur J Clin Pharmacol; 2001 Apr; 57(1):77-83. PubMed ID: 11372597
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Non-compliance with digoxin in patients with heart failure and/or atrial fibrillation: a systematic review and meta-analysis of observational studies.
    Kongkaew C; Sakunrag I; Jianmongkol P
    Arch Cardiovasc Dis; 2012 Oct; 105(10):507-16. PubMed ID: 23062482
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Laboratory evaluation of potassium and creatinine among ambulatory patients prescribed spironolactone: are we monitoring for hyperkalemia?
    Raebel MA; McClure DL; Chan KA; Simon SR; Feldstein AC; Lafata JE; Andrade SE; Gunter MJ; Nelson WW; Roblin D; Platt R
    Ann Pharmacother; 2007 Feb; 41(2):193-200. PubMed ID: 17284506
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of microparticle enzyme and fluorescence polarization immunoassays in pediatric patients not receiving digoxin.
    Chicella M; Branim B; Lee KR; Phelps SJ
    Ther Drug Monit; 1998 Jun; 20(3):347-51. PubMed ID: 9631935
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dose response characterization of the association of serum digoxin concentration with mortality outcomes in the Digitalis Investigation Group trial.
    Adams KF; Butler J; Patterson JH; Gattis Stough W; Bauman JL; van Veldhuisen DJ; Schwartz TA; Sabbah H; Mackowiak JI; Ventura HO; Ghali JK
    Eur J Heart Fail; 2016 Aug; 18(8):1072-81. PubMed ID: 27492641
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Oral salbutamol decreases serum digoxin concentration.
    Edner M; Jogestrand T
    Eur J Clin Pharmacol; 1990; 38(2):195-7. PubMed ID: 2338119
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cystatin C vs creatinine as markers of renal function in patients on digoxin treatment.
    Hallberg P; Melhus H; Hansson LO; Larsson A
    Ups J Med Sci; 2004; 109(3):247-53. PubMed ID: 15508527
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Estimating concentrations of total digoxin and digoxin-like immunoreactive substances in volume-expanded patients being treated with digoxin.
    Dasgupta A; Schammel DP; Limmany AC; Datta P
    Ther Drug Monit; 1996 Feb; 18(1):34-9. PubMed ID: 8848818
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Predictive Factors for Recurrence of Serious Arrhythmias in Patients with Acute Digoxin Poisoning.
    El-Sarnagawy GN; El Sharkawy SI; Helal NE
    Cardiovasc Toxicol; 2021 Oct; 21(10):835-847. PubMed ID: 34259994
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Individual dosage of digoxin in patients with heart failure.
    Muzzarelli S; Stricker H; Pfister O; Foglia P; Moschovitis G; Mombelli G; Brunner-La Rocca H
    QJM; 2011 Apr; 104(4):309-17. PubMed ID: 21062754
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The population pharmacokinetics of digoxin in dogs with heart disease.
    Whittem T; Hogan D; Sisson D; Cooper T
    J Vet Pharmacol Ther; 2000 Aug; 23(4):261-3. PubMed ID: 11126326
    [No Abstract]   [Full Text] [Related]  

  • 75. Identification of severe potential drug-drug interactions using an Italian general-practitioner database.
    Magro L; Conforti A; Del Zotti F; Leone R; Iorio ML; Meneghelli I; Massignani D; Visonà E; Moretti U
    Eur J Clin Pharmacol; 2008 Mar; 64(3):303-9. PubMed ID: 17992523
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis.
    Adams KF; Patterson JH; Gattis WA; O'Connor CM; Lee CR; Schwartz TA; Gheorghiade M
    J Am Coll Cardiol; 2005 Aug; 46(3):497-504. PubMed ID: 16053964
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Omeprazole does not modulate pharmacokinetic of digoxin in patients with heart failure.
    Souza FC; Baptista TM; Marques EB; Barros RB; Scaramello CB
    Int J Cardiol; 2015 Jan; 179():343-4. PubMed ID: 25464482
    [No Abstract]   [Full Text] [Related]  

  • 78. [Drug interaction between digoxin and bisacodyl].
    Wang DJ; Chu KM; Chen JD; Tarn YH; Su DJ
    J Formos Med Assoc; 1990 Oct; 89(10):915-9, 913. PubMed ID: 1981783
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The predictive value of the serum digoxin concentration in the management of hospitalized patients.
    Schapel GJ; Jones TE; Draysey TC; Crocker JM; Davies GT; Robinson MA; Read TR; Stanley PE
    Ther Drug Monit; 1981; 3(2):137-42. PubMed ID: 7268826
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The serum digoxin concentration: ten questions to ask.
    Cauffield JS; Gums JG; Grauer K
    Am Fam Physician; 1997 Aug; 56(2):495-503, 509-10. PubMed ID: 9262530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.